SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-251319
Filing Date
2024-11-05
Accepted
2024-11-05 17:02:30
Documents
13
Period of Report
2024-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d872629d8k.htm   iXBRL 8-K 21889
  Complete submission text file 0001193125-24-251319.txt   147227

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coya-20241101.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20241101_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20241101_pre.xml EX-101.PRE 11725
15 EXTRACTED XBRL INSTANCE DOCUMENT d872629d8k_htm.xml XML 3768
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 241428421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)